Cardiovascular Systems, Inc. to Present at the Raymond James Life Sciences & MedTech Conference
June 11 2019 - 6:00AM
Business Wire
On Tuesday, June 18, 2019, Cardiovascular Systems’ (NASDAQ:
CSII) Chairman, President and Chief Executive Officer, Scott Ward,
will present at the Raymond James Life Sciences & MedTech
Conference at 9:45 a.m. Eastern Time.
You may access the live audio webcast, as well as a replay on
the company’s investor relations website, https://investors.csi360.com/events-and-presentations/events-calendar/default.aspx.
About Cardiovascular Systems, Inc.Cardiovascular Systems,
Inc., based in St. Paul, Minn., is a medical device company focused
on developing and commercializing innovative solutions for treating
vascular and coronary disease. The company’s Orbital Atherectomy
Systems treat calcified and fibrotic plaque in arterial vessels
throughout the leg and heart in a few minutes of treatment time,
and address many of the limitations associated with existing
surgical, catheter and pharmacological treatment alternatives. The
U.S. FDA granted 510(k) clearance for the use of the Diamondback
Orbital Atherectomy System in peripheral arteries in August 2007.
In October 2013, the company received FDA approval for the use of
the Diamondback Orbital Atherectomy System in coronary arteries.
The Stealth 360® Peripheral Orbital Atherectomy System (OAS)
received CE Mark in October 2014. In March 2017, the company
received PMDA approval in Japan for the Diamondback 360® Coronary
OAS Micro Crown and reimbursement approval effective February 2018.
Over 450,000 of CSI’s devices have been sold to leading
institutions worldwide. For more information, visit the company’s
website at www.csi360.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190611005005/en/
Cardiovascular Systems, Inc.Jack Nielsen(651)
202-4919j.nielsen@csi360.com
PadillaMatt Sullivan(612)
455-1709matt.sullivan@padillaco.com
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Mar 2024 to Apr 2024
Cardiovascular Systems (NASDAQ:CSII)
Historical Stock Chart
From Apr 2023 to Apr 2024